The relationship between the local and systemic Inflammatory Responses and Survival in Patients Undergoing Curative Surgery for Colon and Rectal Cancers

Journal of Gastrointestinal Surgery

Volumn 13, Issue 11, 2009, Pages 2011-2019

  Roxburgh, Campbell S D ^a   Salmond, Jonathan M ^a   Horgan, Paul G ^a   Oien, Karin A ^a   Mcmillan, Donald C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Colorectal cancer; Curative resec; Glasgow Prognostic Score; Local inflammation; Survival; Systemic inflammation

Indexed keywords

C REACTIVE PROTEIN; SERUM ALBUMIN;

AGED; ARTICLE; CANCER INVASION; COLON; COLON TUMOR; FEMALE; HUMAN; INFLAMMATION; MALE; MORTALITY; PATHOLOGY; PROGNOSIS; RECTUM; RECTUM TUMOR; SURVIVAL;

AGED; C-REACTIVE PROTEIN; COLON; COLONIC NEOPLASMS; FEMALE; HUMANS; INFLAMMATION; MALE; NEOPLASM INVASIVENESS; PROGNOSIS; RECTAL NEOPLASMS; RECTUM; SERUM ALBUMIN; SURVIVAL ANALYSIS;

EID: 77952973965     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-1034-0     Document Type: Article

References (36)

1. Cancerstats, 2004; www.cancerresearchuk.org.
2. McArdle CS, Hole DJ. Outcome following surgery for colorectal cancer: analysis by hospital after adjustment for case-mix and deprivation. Br J Cancer 2002;86:331-335.
3. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I. EUROCARE-4 Working Group. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007;8(9):784-796
4. Vakilla J, Lotze MT. Inflammation and necrosis promote tumour growth. Nature Cancer Reviews 2004;4:641-648
5. McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 2009;12:223-226.
6. Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet 1987;1(8545):1303-1306
7. Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 1997;182:318-324
8. Nielsen HJ, Hansen U, Christensen IJ, Reimert SM, Brunner N, Moesgaard F. Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol 1999;189:487-495.
9. Klintrup K, Makinen JM, Kauppila S, Vare PO, Melkko J, Tuominen H, Tuppurainen K, Makela J, Karttunen TJ, Makinen MJ. Inflammation and prognosis in colorectal cancer. Eur J Cancer 2005;41:2645-2654.
10. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pagès F. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006;313(5795):1960-1964.
11. Roxburgh CSD, Salmond JM, Horgan PG, Oien KA, McMillan DC. Tumour inflammatory infiltrate predicts survival following curative resection for node negative colorectal cancer. Eur J Surg 2009;45(12):2138-2145.
12. McMillan DC, Crozier JE, Canna K, Angerson WJ, McArdle CS. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 2007;22:81-86.
13. Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 2007;246:1047-1051.
14. Roxburgh CSD, Salmond JM, Horgan PG, Oien KA, McMillan DC. Comparison of the prognostic value of inflammation based patho-logical and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg 2009;249(5): 788-793.
15. Cengiz M, Akbulut S, Atahan IL, Grigsby PW. Acute phase response during radiotherapy. Int J Radiat Oncol Biol Phys 2001;49:1093-1096.
16. Koc M, Taysi S, Sezen O, Bakan N. Levels of some acute-phase proteins in the serum of patients with cancer during radiotherapy. Biol Pharm Bull 2003;26:1494-1497.
17. Williams TJ, Quirke P, Shepherd NA. RCPath cancer services working group. Dataset for colorectal cancer 2nd Edition. September 2007. www.rcpath.org.uk.
18. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;1(8496):1479-1482
19. Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 2003;89:1028-1030.
20. McMillan DC. An inflammation-based prognostic score and its role in the nutrition based management of patients with cancer. Proc Nutr Soc 2008;67:257-262.
21. Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 2006;83:735-743
22. Fearon KC, Voss AC, Hustead DS, Cancer Cachexia Study Group. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 2006;83:1345-1350
23. Du Klos TW, Mold C. C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity. Immunol Res 2004;30(3):261-277.
24. Canna K, McArdle PA, McMillan DC, McNicol AM, Smith GW, McKee RF, McArdle CS. The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer 2005;92(4):651-654.
25. de Jong KP, Hoedemakers RM, Fidler V, Bijzet J, Limburg PC, Peeters PM, deVries EG, Slooff MJ. Portal and systemic serum growth factor and acute-phase response after laparotomy or partial hepatectomy in patients with colorectal liver metastases: a prognostic role for C-reactive protein and hepatocyte growth factor. Scand J Gastroenterol 2004;39:1141-1148.
26. Krzystek-Korpacka M, Matusiewicz M, Diakowska D, Grabowski K, Blachut K, Kustrzeba-Wojcicka I, Terlecki G, Gamian A. Acute-phase response proteins are related to cachexia and accelerated angiogenesis in gastroesophageal cancers. Clin Chem Lab Med 2008;46:359-364.
27. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009;30:1073-1081
28. Heys SD, Walker LG, Deehan DJ, Eremin OE. Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb 1998;43(3):163-168.
29. Al Murri AM, Bartlett JM, Canney PA, Doughty JC, Wilson C, McMillan DC. Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer 2006;94:227-230.
30. Crumley AB, McMillan DC, McKernan M, McDonald AC, Stuart RC. Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. Br J Cancer 2006;94:637-641.
31. Ellegård LH, Bosaeus IG. Biochemical indices to evaluate nutritional support for malignant disease. Clin Chim Acta 2008; 390:23-27.
32. McMillan DC, Watson WS, O'Gorman P, Preston T, Scott HR, McArdle CS. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 2001;39:210-213
33. Hashimoto K, Ikeda Y, Korenaga D, Tanoue K, Hamatake M, Kawasaki K, Yamaoka T, Iwatani Y, Akazawa K, Takenaka K. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 2005;103(9):1856-1864.
34. Malik HZ, Prasad KR, Halazun KJ, Aldoori A, Al-Mukhtar A, Gomez D, Lodge JP, Toogood GJ. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg 2007;246(5):806-814.
35. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005;91:181-184.
36. Iimura Y, Saito K, Fujii Y, Kumagai J, Kawakami S, Komai Y, Yonese J, Fukui I, Kihara K. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score. J Urol 2009;181(3):1004-1012.